Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Electronic Resource  (5)
  • 1990-1994  (5)
  • 1
    ISSN: 1520-4804
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1420-908X
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The effect of complement fragments on coronary blood flowin vivo and the contraction of coronary arteriesin vitro was determined. In pentobarbital anesthetized dogs, intraarterial bolus injection of C3a and C5a, zymosan-activated serum and methylcholine in the coronary vascular bed caused transient and dose-dependent increases in coronary blood flow. Similar increases were obtained with 25 μg of C3a (104±13%,n=5) and 0.1 μg of methylcholine (102±4%,n=3). Smaller, increases in blood flow were elicited by 25 μg of C5a (41±18%,n=4) and 0.2 ml, of zymosan-activated serum (48±5%,n=4). None of these responses were associated, with significant changes in left ventricular contractile force measured with a strain gauge, arterial blood pressure, and heart rate. C3a dilated the coronary vascular bed in conscious dogs with an activity equal to or greater than that observed in anesthetized dogs. Isolated canine coronary arteries that were precontracted with serotonin relaxed in response to C3a, whether or not the endothelium was intact. Overall these data suggest that physiologically high doses of anaphylactic complement fragments vasodilate the canine coronary circulation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of cancer research and clinical oncology 116 (1990), S. 439-442 
    ISSN: 1432-1335
    Keywords: D-19466 ; New drug ; Platinum complex ; Antitumor activity ; Pre-clinical
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary D-19466, a new platinum complex, was characterized. It showed no nephrotoxic side-effects as determined by the measurement of blood urea. It was cytotoxic in vitro for tumor cells in concentrations comparable to or lower than cytotoxic concentrations of cisplatin. It had excellent anticancer activity in vivo against a number of murine experimental tumors, including a cisplatin-resistant P388 line. Clinical evaluation of this compound has therefore been initiated.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Basic research in cardiology 86 (1991), S. 99-106 
    ISSN: 1435-1803
    Keywords: myocardial infarction ; thromboxane A2 ; aspirin ; coronary blood flow ; infarct size
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary A previous study indicated that 5 mg/kg aspirin can reverse the cardioprotective effects of thromboxane A2 synthetase inhibitors. We determined in the present study if this dose of aspirin can also reverse the protective effects of the thromboxane A2/PGH2 receptor antagonist SQ 30,741 in the same model of coronary occlusion and reperfusion. Anesthetized dogs were subjected to 90 min of coronary occlusion and 5 h of reperfusion and were treated with vehicle or SQ 30,741 (1 mg/kg + 1 mg/kg/h) 10 min after the onset of coronary occlusion. SQ 30,741 was given to dogs pretreated with aspirin (5 mg/kg, 24 h presurgery) or vehicle. SQ 30,741 significantly reduced infarct size compared to vehicle treatment (58 % vs 35 % of the left ventricular area at risk for vehicle and SQ 30,741 groups respectively) and aspirin did not reverse this. These anti-ischemic effects occurred despite a lack of change in collateral flow. Thus, important differences in mechanism of action between thromboxane synthesis inhibitors and receptor antagonists seem to exist and further work in this area is warranted.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    The European physical journal 83 (1991), S. 295-302 
    ISSN: 1434-6036
    Source: Springer Online Journal Archives 1860-2000
    Topics: Physics
    Notes: Abstract Two-level systems under the influence of external noise are generic models of quantum relaxation processes. The spin 1/2 particle in a stochastic magnetic field is one of the best known examples. Interesting effects are observed if the noise is colored as is the case in most applications. The time-ordered operator cumulant expansion forms a convenient approach to this problem. Recently, a renormalization procedure has been proposed which corresponds to a partial summation of the naive expansion and hence constitutes an essential improvement over the second cumulant considered usually. For colored noise of intermediate strength and correlation time this approach is used to derive renormalized expressions for the transverse (T 2) and longitudinal (T 1) relaxation time and the frequency shift. In this parameter region, the ratioT 1/T 2=α is found to deviate substantially from its value α=2 valid for white noise exactly and for colored noise in the second cumulant approximation. This corroborates and extends results of Budimir and Skinner obtained by including the second and fourth cumulant only. However, their truncated expansion is shown to lead to unphysical results in the intermediate parameter region treated still correctly by the renormalized expansion.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...